Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-31
2007-07-31
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S124000
Reexamination Certificate
active
10543828
ABSTRACT:
This invention relates to novel 8-aza-bicyclo[3.2.1]octane derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
REFERENCES:
patent: 5554626 (1996-09-01), Moldt et al.
patent: 0 604 354 (1994-06-01), None
patent: WO-97/30997 (1997-08-01), None
patent: WO-03/014114 (2003-02-01), None
patent: WO-03/045388 (2003-06-01), None
Gyorgy et al., Acta Physiologica Academiae Scientiarum Hungaricae, “Pharmacological studies on new tertiary tropine esters”, 1960, vol. 17, pp. 474-477.
Nielsen Elsebet Østergaard
Olsen Gunnar M.
Peters Dan
Scheel-Kruger Jørgen
NeuroSearch A/S
Rahmani Niloofar
Seaman Margaret D.
LandOfFree
8-aza-bicyclo[3.2.1]octane derivatives and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-aza-bicyclo[3.2.1]octane derivatives and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-aza-bicyclo[3.2.1]octane derivatives and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3763871